Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… a tapering regimen at 1 mg/Kg/day), tocilizumab (8 mg/kg), and anakinra (200 mg/day). The clinical pharmacist followed the patient thro…
…CSF. We gave methylprednisolone, plasma exchange, rituximab and cyclophosphamide. However, despite initial improvement, he had five relapses. We…
…term consequences and significant risk of longer-term morbidity.Tocilizumab is a humanized monoclonal antibody against the IL-6 receptor, u…
…aricitinib (n=2), convalescent plasma (n=1), anakinra (n=1) and vilobelimab (n=1)). DISCERN (median (IQR)) reliability was 4 (IQR 3–4) and …
… lung disease progressed to respiratory failure. Treatment with tocilizumab led to clinical and radiological remission with normalisation o…
…4% following prompt neuro-hormonal blockade and IL-6 blockade - tocilizumab made more difference. Another patient developed acute pulmonary…
…assesses impact of IL11/6 signalling inhibitors (e.g. LASN01 or tocilizumab) in hAFbs in context of AF to dampen pro-fibrotic phenotypes of…
…isomerase I positive. TCZ monotherapy was used in 29% of cases, methotrexate was the most frequent combined treatment (35%). In SSc-associat…
…ry review to validate its off-label use. The treatment included hydrocortisone (100 mg), acetaminophen (1 g), and dexchlorpheniramine (5 mg), …
… (SSc) patients. The recent ERS/EULAR guidelines recommend both mycophenolate mofetil (MMF) and rituximab (RTX) for SSc-ILD and suggest to use a comb…
…analyze long term outcome of patients with SSc-ILD treated with tocilizumab (TCZ), rituximab (RTX), and abatacept (ABA) which became availa…
…urgitation. Exposure to immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine, cyclophosphamide, tacrolimus, leflunomide, ritux…